CTRI/2024/02/062844尚未招募Unknown
Treatment outcomes with extra-fine beclomethasone-formoterol in patients with uncontrolled asthma - NI
Cipla Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Inclusion Criteria
- •1.Male and female participants more than equal to 18 years of age
- •2.Asthma patients uncontrolled on ICS LABA combination
- •3.Have been prescribed Niveoli for the very first time.
排除标准
- •Exclusion criteria
- •1.Participants below the age of 18 years
- •2.Participants unable to perform spirometry or and lung oscillometry.
- •3.Participants not willing to provide consent to participate.
研究者
相似试验
已完成
不适用
Trial of Beclomethasone dipropionate versus Budesonide inhaler therapy in mild persistent asthma in childreCTRI/2013/03/003495A85
进行中（未招募）
1 期
Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP/FF), as reliever, upon exhaled nitric oxide in asthma. FENOMENO study (Fractional Exhaled Nitric Oxide-Multiple Expiration flow of NO). A single-centre, placebo controlled, randomized, double blind, cross-over study - FenomenoModerate asthmaMedDRA version: 9.1 Level: LLT Classification code 10003553 Term: AsthmaEUCTR2007-004377-26-GBChiesi Farmaceutici S.p.A.20
已完成
Unknown
• Investigating the Effect of Betamethasone Ophthalmic Ointment in Reducing the Recurrence of Polyposis After Frontal Sinus SurgeryIRCT20220510054810N1Iran University of Medical Sciences30
进行中（未招募）
不适用
Efficacy and safety of Beclomethasone dipropionate, gastro-resistant, prolonged release tablets (CHF1514) compared to oral prednisone, in a 8-week treatment period, in patients with active ulcerative colitis. An international, multicentre, randomized, double blind, parallel group study. - Beta studylcerative colitis extending proximally beyond the rectum.MedDRA version: 9.1Level: LLTClassification code 10045365Term: Ulcerative colitisEUCTR2006-004230-32-BECHIESI Farmaceutici S.p.A.300
已完成
不适用
Efficacy and safety of Beclomethasone dipropionate, gastro-resistant, prolonged release tablets (CHF1514) compared to oral prednisone, in a 8-week treatment period, in patients with active ulcerative colitis. An international, multicentre, randomized, double blind, parallel group study.Mild to moderate Ulcerative colitisOral and Gastrointestinal - Inflammatory bowel diseaseACTRN12609001010280Chiesi Farmaceutici S.p.A.244